Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinzhihuang oral solution for term neonatal hyperbilirubinemia
ChiCTR-TRC-10000847Phase 4Completed
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Apr 2010
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of yinzhihuang and phenobarbital in neonatal hyperbilirubinemia (3 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Change in bilirubin level. Started Apr 2010; status: completed.
02
Drugs
yinzhihuangphenobarbital
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on ChiCTR-TRC-10000847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000847.